Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atopic Hypersensitivity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06732414
What this trial is testing

A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-Up

Who this might be right for
Allergy, Sinus Disorders, Atopic Diseases, Asthma, Allergic Rhinitis, Atopic Dermatitis, EoE, Drug a
National Institute of Allergy and Infectious Diseases (NIAID) 10,000
Not applicableStudy completedNCT07703215
What this trial is testing

NPQ Plus Supplementation for Skin Health and Antioxidant Status

Who this might be right for
EczemaAtopic DermatitisSkin Health+4 more
N REMEDIER (M) SDN BHD 55
Large-scale testing (Phase 3)Study completedNCT05990725
What this trial is testing

Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic DermatitisEczema
Almirall, S.A. 260
Testing effectiveness (Phase 2)Study completedNCT00118625
What this trial is testing

Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Tree Pollen Allergy Vaccine

Who this might be right for
Type I Hypersensitivity
Allergy Therapeutics 40
Testing effectiveness (Phase 2)Study completedNCT02594098
What this trial is testing

Secukinumab for Treatment of Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Icahn School of Medicine at Mount Sinai 41
Testing effectiveness (Phase 2)Ended earlyNCT05222516
What this trial is testing

Immunomodulation by OM-85 (Broncho-Vaxom) in Early AD

Who this might be right for
Atopic Dermatitis
OM Pharma SA 63
Testing effectiveness (Phase 2)Study completedNCT04684485
What this trial is testing

To Assess the Efficacy and Safety of SCD-044 in the Treatment of Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Sun Pharmaceutical Industries Limited 250
Not applicableEnded earlyNCT03684343
What this trial is testing

Comparative Analysis of Filmed Sequences for the Assessment of Discomfort in Atopic Dermatitis of Infants Under 6 Months of Age

Who this might be right for
Atopic Dermatitis
University Hospital, Brest 48
Large-scale testing (Phase 3)Study completedNCT06173284
What this trial is testing

Evaluation of 611(Recombinant Humanized Anti-interleukin-4 Receptor Alpha IgG4 Monoclonal Antibody) in Chinese Adults With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 519
Testing effectiveness (Phase 2)Study completedNCT00258635
What this trial is testing

Investigation of Safety+Efficacy of Different Doses of RagweedMATAMPL;Assessment of Residual Allergenicity Using Skin Prick Test

Who this might be right for
Type I Hypersensitivity
Allergy Therapeutics 69
Testing effectiveness (Phase 2)Ended earlyNCT04037891
What this trial is testing

Topical rVA576 for Treatment of Atopic Keratoconjunctivitis

Who this might be right for
Keratoconjunctivitis, AtopicKeratoconjunctivitis, VernalConjunctivitis, Allergic
AKARI Therapeutics 12
Early research (Phase 1)UnknownNCT05724290
What this trial is testing

Mechanism of EGR2 in Allergic Rhinitis

Who this might be right for
Rhinitis, Allergic
Zu-xia Ma 3
Testing effectiveness (Phase 2)Ended earlyNCT04936113
What this trial is testing

Continued Safety Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis Previously Enrolled in the FB401-01 Study

Who this might be right for
Atopic Dermatitis
Forte Biosciences, Inc. 36
Not applicableActive Not RecruitingNCT03687359
What this trial is testing

Observational Evaluation of Atopic Dermatitis in Pediatric Patients

Who this might be right for
Dermatitis Atopic
Sanofi 1,860
Early research (Phase 1)Study completedNCT01959113
What this trial is testing

Validation of the Short-term Antimicrobial Action of Transplanted Bacteria

Who this might be right for
Atopic Dermatitis
University of California, San Diego 5
Not applicableLooking for participantsNCT06636240
What this trial is testing

Prebiotic Effects of Mulberry Fruit in Children and Adolescents With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (Eczema)Atopic Dermatitis, Probiotics
Taipei Medical University Shuang Ho Hospital 120
Post-approval studies (Phase 4)Study completedNCT04271007
What this trial is testing

Comparative Study:Topison (Mometasone Furoate) Versus Two Others Mometasone Furoates

Who this might be right for
Atopic Dermatitis
Libbs Farmacêutica LTDA 32
Not applicableStudy completedNCT07016087
What this trial is testing

Therapeutic Efficacy of Cutaneous Application of Postbiotic N-(1-carbamoyl-2-phenyl-ethyl) Butyramide (FBA) in Pediatric Subjects Affected by Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Federico II University 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT06727552
What this trial is testing

Barzolvolimab in Patients With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Celldex Therapeutics 131
Not applicableLooking for participantsNCT00177268
What this trial is testing

Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

Who this might be right for
Cutaneous T-cell LymphomaSezary SyndromeMycosis Fungoides+2 more
University of Pittsburgh 200
Next Page